Xianming Deng
Impact in
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid
- Molecular Biology top 2%
- Inflammasome and immune disorders
- Melanoma and MAPK Pathways
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 13
- Ubiquitin and proteasome pathways 10
- Melanoma and MAPK Pathways 8
- Inflammasome and immune disorders 7
- Protein Degradation and Inhibitors 7
-
- Quinazolinone synthesis and applications 7
- Co-authors
- Nathanael S. Gray (36 shared papers)Rongbin Zhou (8 shared papers)Wei Jiang (3 shared papers)Qingsong Liu (4 shared papers)Hongbin He (5 shared papers)Yong Tang (12 shared papers)Chao Wang (2 shared papers)Aoli Wang (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of Medicinal Chemistry (7 papers)Nature Communications (6 papers)European Journal of Medicinal Chemistry (4 papers)Cancer Research (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xianming Deng
138 papers receiving 6.8k citations
Xianming Deng's Hit Papers
Peers
Comparison fields: 5 of 147
- Nephrology 373
- Molecular Biology 3.6k
- Neurology 646
- Biological Psychiatry 100
- Immunology 801
Countries citing papers authored by Xianming Deng
This map shows the geographic impact of Xianming Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianming Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianming Deng more than expected).
Fields of papers citing papers by Xianming Deng
This network shows the impact of papers produced by Xianming Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianming Deng. The network helps show where Xianming Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xianming Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity Hit paper breakdown → | 2018 | 638 |
| 2 | Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders Hit paper breakdown → | 2017 | 616 |
| 3 | Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases Hit paper breakdown → | 2018 | 435 |
| 4 | 2011 | 357 | |
| 5 | TLR4 signalling via Piezo1 engages and enhances the macrophage mediated host response during bacterial infection Hit paper breakdown → | 2021 | 205 |
| 6 | 2006 | 167 | |
| 7 | 2010 | 155 | |
| 8 | 2015 | 145 | |
| 9 | 2019 | 141 | |
| 10 | 2012 | 126 | |
| 11 | 2016 | 117 | |
| 12 | 2021 | 114 | |
| 13 | 2020 | 112 | |
| 14 | 2012 | 109 | |
| 15 | 2017 | 105 | |
| 16 | 2011 | 96 | |
| 17 | 2008 | 96 | |
| 18 | 2022 | 94 | |
| 19 | 2021 | 94 | |
| 20 | 2018 | 93 |
About Xianming Deng
Xianming Deng is a scholar working on Molecular Biology, Organic Chemistry, Cell Biology, Oncology and Hematology, having authored 146 papers that have together received 6.9k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (13 papers), Ubiquitin and proteasome pathways (10 papers), Microbial Natural Products and Biosynthesis (9 papers), Melanoma and MAPK Pathways (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Inflammasome and immune disorders (7 papers), Protein Degradation and Inhibitors (7 papers) and Quinazolinone synthesis and applications (7 papers). The work is most often cited by research in Nephrology (373 citations), Molecular Biology (3.6k citations), Neurology (646 citations), Biological Psychiatry (100 citations) and Immunology (801 citations). Xianming Deng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Nathanael S. Gray, Rongbin Zhou, Wei Jiang, Qingsong Liu, Hongbin He, Yong Tang, Chao Wang, Aoli Wang, Yun Chen and Hua Jiang. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Nature Communications, European Journal of Medicinal Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.